CAPTRUST Financial Advisors
CYTK icon

CAPTRUST Financial Advisors’s Cytokinetics CYTK Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$558K Buy
6,550
+2,186
+50% +$157K ﹤0.01% 2106
2026
Q1 		$288K Sell
4,364
-285
-6% -$18.1K ﹤0.01% 2420
2025
Q4 		$295K Buy
+4,649
New +$289K ﹤0.01% 2266
2024
Q1 		– Sell
-12,258
Closed -$1.02M – 2284
2023
Q4 		$1.02M Sell
12,258
-2,948
-19% -$107K ﹤0.01% 1254
2023
Q3 		$448K Buy
15,206
+5,035
+50% +$168K ﹤0.01% 1711
2023
Q2 		$332K Sell
10,171
-18
-0.2% -$666 ﹤0.01% 1897
2023
Q1 		$359K Sell
10,189
-687
-6% -$28K ﹤0.01% 1611
2022
Q4 		$498K Buy
10,876
+6,699
+160% +$288K ﹤0.01% 1331
2022
Q3 		$202K Buy
4,177
+304
+8% +$14.6K ﹤0.01% 1816
2022
Q2 		$152K Sell
3,873
-37
-0.9% -$1.49K ﹤0.01% 1894
2022
Q1 		$144K Buy
3,910
+1,735
+80% +$61.6K ﹤0.01% 1973
2021
Q4 		$99K Buy
2,175
+18
+0.8% +$695 ﹤0.01% 2174
2021
Q3 		$77K Buy
2,157
+43
+2% +$1.27K ﹤0.01% 2279
2021
Q2 		$42K Sell
2,114
-17
-0.8% -$399 ﹤0.01% 2623
2021
Q1 		$50K Buy
2,131
+1,991
+1,422% +$42.5K ﹤0.01% 2425
2020
Q4 		$3K Sell
140
-260
-65% -$4.75K ﹤0.01% 2986
2020
Q3 		$9K Buy
+400
New +$9.36K ﹤0.01% 2319

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAPTRUST Financial Advisors's CYTK Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Cytokinetics (CYTK) stake by 50% in Q2 2026, buying an estimated $157K and bringing the position to 6,550 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

CAPTRUST Financial Advisors first reported a position in CYTK in Q3 2020 and has held it in 17 quarters since. The position peaked at $1.02M in Q4 2023. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • CAPTRUST Financial Advisors held 6,550 shares of Cytokinetics worth $558K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 2,186 Cytokinetics shares in Q2 2026, an estimated $157K.
  • Cytokinetics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2106 holding.
  • CAPTRUST Financial Advisors first reported a position in Cytokinetics in Q3 2020 and has held it in 17 quarters since.
  • CAPTRUST Financial Advisors's Cytokinetics position peaked at $1.02M in Q4 2023.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.